American Academy

THE AMERICAN ACADEMY OF COSMETIC SURGERY (AACS) IS NOW ACCEPTING APPLICATIONS FOR TWO AACS CERTIFIED COSMETIC SURGERY FELLOWSHIP TRAINING PROGRAMS

Retrieved on: 
Monday, April 1, 2024
AACS, Interest, DDS, Patient, Breast, American Academy, Surgeon, Plastic surgery, Rhinoplasty, Skin, Blepharoplasty, Extremities, FACS, DMD, Physician, Dentistry

CHICAGO, April 1, 2024 /PRNewswire/ -- The American Academy of Cosmetic Surgery (AACS), the world's largest multi-specialty organization for physicians dedicated to cosmetic surgery and aesthetic medicine, is accepting applications for July 2025 cohort positions for two types of AACS Certified Fellowship Training Programs. Applications are due by June 1, 2024.

Key Points: 
  • Applications for AACS Certified Cosmetic Surgery Fellowships in General Cosmetic Surgery and Facial Cosmetic Surgery, which offer comprehensive, world-class training, will be accepted until June 1, 2024 for July 2025 cohort positions
    CHICAGO, April 1, 2024 /PRNewswire/ -- The American Academy of Cosmetic Surgery (AACS) , the world's largest multi-specialty organization for physicians dedicated to cosmetic surgery and aesthetic medicine, is accepting applications for July 2025 cohort positions for two types of AACS Certified Fellowship Training Programs.
  • AACS Certified Cosmetic Surgery Fellowships are the only cosmetic surgery training programs that fully prepare physicians for a career in cosmetic surgery, offering extraordinary opportunities for intensive, hands-on training in a vast array of cosmetic surgery procedures alongside some of the world's leading cosmetic surgeons.
  • Offered in General Cosmetic Surgery and Facial Cosmetic Surgery, these Certified Fellowships are post‐residency programs involving advanced education and comprehensive training in the art of general cosmetic surgery and facial cosmetic surgery.
  • Ryan Diepenbrock, DDS, FAACS, Chair of the Facial Cosmetic Surgery Fellowship Committee, adds, "AACS Fellowships provide the training needed to successfully practice as a cosmetic surgeon.

Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States

Retrieved on: 
Monday, April 1, 2024
Glaucoma, Agonist, Rheumatoid arthritis, Phenylephrine, Diabetes, Inflammation, Patient, Ageing, American Optometric Association, Eye injury, American Academy, Mydriasis, United, Viatris, Eye, Parasympatholytic, Uveitis, Lens, Pupil, Tropicamide, FDA, Cataract, Diabetic retinopathy, Food, Pharmaceutical industry

PITTSBURGH, April 1, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the U.S. commercial launch of RYZUMVI™ (phentolamine ophthalmic solution) 0.75% for the treatment of pharmacologically-induced mydriasis produced by adrenergic agonists (e.g., phenylephrine) or parasympatholytic (e.g., tropicamide) agents in the United States.

Key Points: 
  • PITTSBURGH, April 1, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the U.S. commercial launch of RYZUMVI™ (phentolamine ophthalmic solution) 0.75% for the treatment of pharmacologically-induced mydriasis produced by adrenergic agonists (e.g., phenylephrine) or parasympatholytic (e.g., tropicamide) agents in the United States.
  • The onset of action of RYZUMVI generally occurs in 30 minutes.
  • In the MIRA-2 trials' placebo group, 34% of patients were still dilated (had not returned to ≤ 0.2 mm of baseline pupil diameter) at 24 hours.
  • To avoid the potential for eye injury or contamination, care should be taken to avoid touching the vial tip to the eye or to any other surface.

Leading Prosthetics Manufacturer WillowWood Acquires Innovative Socket Manufacturer Xtremity

Retrieved on: 
Thursday, March 28, 2024
Carbon, Orthotist, American Academy

DENVER, March 28, 2024 /PRNewswire/ -- WillowWood Global, a leading designer, manufacturer, and distributor of prosthetic products, today announced that it has acquired Xtremity.

Key Points: 
  • DENVER, March 28, 2024 /PRNewswire/ -- WillowWood Global, a leading designer, manufacturer, and distributor of prosthetic products, today announced that it has acquired Xtremity.
  • Based in Denver, Colorado, Xtremity was formed in 2017 and successfully patented and commercialized a unique socket "preform" using a proprietary carbon reinforced polymer.
  • "Acquiring Xtremity supports our strategy at WillowWood to focus on leveling the playing field for clinicians by empowering them to optimize patient outcomes.
  • Mahesh Mansukhani, CEO of WillowWood, added "We've followed Xtremity's progress for some time and are very excited to fully integrate it into WillowWood.

Prevent Blindness Provides Free Resources as Part of April's Women's Eye Health and Safety Month to Educate Women on Necessary Steps to Help Save Sight

Retrieved on: 
Wednesday, March 27, 2024
Orbis, IOP, Pigment, Glaucoma, Le Bonheur Children's Hospital, Social media, Pressure, Visual impairment, Contact, Paratriathlon, Intraocular pressure, AAO, Policy, Orbis International, Hormone, Diabetes, Risk, Mental health, Delta Gamma, NIH, Eyelid, Prevalence, Eye, Associate, Safety, Cataract, Menopause, University, Pregnancy, Hospital, Melasma, Public health, Lactation, Puberty, American Academy, Lens, Telecanthus, Eye disease, Graves' ophthalmopathy, Bangladesh Technical Education Board, Dry eye syndrome, Pediatrics, Birth control

CHICAGO, March 27, 2024 /PRNewswire-PRWeb/ -- Prevent Blindness, the nation's leading nonprofit eye health organization, has declared April as Women's Eye Health and Safety Month. According to Orbis International, globally there are 112 million more women than men living with vision loss, including blindness. Prevent Blindness is offering free resources, including fact sheets, shareable social media graphics, educational videos and web pages, on a range of eye health issues that predominantly affect women.

Key Points: 
  • CHICAGO, March 27, 2024 /PRNewswire-PRWeb/ -- Prevent Blindness , the nation's leading nonprofit eye health organization, has declared April as Women's Eye Health and Safety Month.
  • Prevent Blindness is offering free resources, including fact sheets, shareable social media graphics, educational videos and web pages, on a range of eye health issues that predominantly affect women.
  • Women have a higher prevalence of age-related macular degeneration, cataract, dry eye, glaucoma, refractive error and thyroid eye disease.
  • For more information on women's eye health topics, including fact sheets on eye diseases and eye safety, please visit PreventBlindness.org.

New scientific paper exposes serious flaws in fluoride-IQ studies

Retrieved on: 
Monday, March 25, 2024
Deficit spending, Pregnancy, Health, Conditional sentence, Database, Public health, BMC Public Health, Intelligence, Risk, Bias, Family medicine, JAMA Pediatrics, Journal, Fetus, Research, Tooth decay, Policy, Water, American Academy, University, American Dental Association, Systematic review, Drinking, Intelligence quotient, Pediatrics (journal), Pediatrics, Meta-analysis, Bottled water

WASHINGTON, March 25, 2024 /PRNewswire/ -- Hundreds of millions of people around the world receive significant dental health benefits because their tap water is adjusted to the recommended amount of fluoride. Yet opponents of water fluoridation often cite a 2019 Canadian study (Green et al.) to claim that fluoride affects children's IQ scores. This claim has been refuted by a new peer-reviewed analysis. This published analysis shows that the Canadian researchers relied on data that cannot report fluoride measurement and does not accurately measure IQ.

Key Points: 
  • The authors of this analysis wrote that studies relying on these data to make claims about fluoride and IQ "should be considered unacceptable for legal and policy purposes."
  • When the researchers compared the average IQ score between fluoridated and non-fluoridated cities in Canada, the scores were virtually identical.
  • In fact, a 2023 systematic review examined 30 fluoride-IQ studies and found that 29 studies were at moderate to high risk of bias (lower quality).
  • For more information on the scientific evidence related to fluoride and fluoridation, please visit the American Fluoridation Society at AmericanFluoridationSociety.org.

THE DERMATOLOGY FOUNDATION AND SKIN OF COLOR SOCIETY BESTOW THE FIRST-EVER SANOFI AND REGENERON DIVERSITY, EQUITY, AND INCLUSION MID-CAREER AWARD ON DONALD A. GLASS II, MD, PhD, FAAD

Retrieved on: 
Tuesday, March 19, 2024
SOCS, Autoimmunity, University, Glass, Regeneron Pharmaceuticals, Associate, Health equity, Genetics, Patient, DF, Research, Diversity, American Academy, Doctor of Philosophy, MBA, Skin, University of Massachusetts, MPH, Comorbidity, FAAD, Bangladesh Technical Education Board, DEI, Vitiligo, Medicine, Pharmaceutical industry

CHICAGO, March 19, 2024 /PRNewswire/ -- The Dermatology Foundation (DF) and the Skin of Color Society (SOCS) announce that Donald A. Glass II, MD, PhD, FAAD, is the 2024 recipient of the first-ever Sanofi and Regeneron Diversity, Equity, and Inclusion (DEI) Mid-Career Award, given to support his research into "Genetics, Comorbidities and their Association with Keloids."

Key Points: 
  • A nationally recognized keloids expert, Dr. Glass is an Associate Professor at the University of Texas Southwestern Medical Center in Dallas, Texas.
  • He served as 2021-2022 President of the Skin of Color Society.
  • The Sanofi and Regeneron DEI Mid-Career Award was developed especially for the exceptional mid-career investigator with an established trajectory of excellence in basic, clinical or translational science.
  • Our sincere congratulations to Dr. Glass, the outstanding first award recipient for this highly competitive award—and our sincere gratitude to Sanofi and Regeneron for making the award possible."

New Autism Therapy Clinic Opens its Doors to Families in Cedar Rapids Area

Retrieved on: 
Wednesday, March 13, 2024
Diagnosis, LBA, Caravel, BCBA, Child, American Academy, Applied behavior analysis, Senior counsel, Language, ABA, Spectrum, Pediatrics (journal), Pediatrics, Nursing

HIAWATHA, Iowa, March 13, 2024 /PRNewswire/ -- Caravel Autism Health , a leader in the diagnosis and treatment of young children on the autism spectrum, is hosting a ribbon-cutting ceremony on Thursday, March 14 to celebrate the grand opening of a new, state-of-the-art autism therapy clinic for families in the Cedar Rapids area.

Key Points: 
  • HIAWATHA, Iowa, March 13, 2024 /PRNewswire/ -- Caravel Autism Health , a leader in the diagnosis and treatment of young children on the autism spectrum, is hosting a ribbon-cutting ceremony on Thursday, March 14 to celebrate the grand opening of a new, state-of-the-art autism therapy clinic for families in the Cedar Rapids area.
  • We're excited to be opening our doors to families across the Cedar Rapids area."
  • "For a child with autism, the ideal scenario is early diagnosis and therapy," explained Emily Harriott MA, BCBA, LBA, clinic director for Caravel in Cedar Rapids.
  • Harriott and her team at Caravel's Cedar Rapids clinic are currently enrolling new clients for evaluation and treatment.

The Inner Circle acknowledges Richard L. Van Buskirk, DO as a Distinguished Lifetime Member

Retrieved on: 
Wednesday, March 13, 2024
Gardening, Patient, Duke University, American Academy, Doctor of Philosophy, Osteopathy, Bachelor, Psychology, Music, Multimedia, Mercer University, Health, Inner circle, Medicine, Veterinary medicine

SARASOTA, Fla., March 13, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Richard L. Van Buskirk, DO is acknowledged as a Distinguished Lifetime Member for his contributions in Osteopathic Medicine.

Key Points: 
  • SARASOTA, Fla., March 13, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Richard L. Van Buskirk, DO is acknowledged as a Distinguished Lifetime Member for his contributions in Osteopathic Medicine.
  • Dr. Richard L. Van Buskirk, an esteemed practitioner in the field of osteopathic medicine, is recognized for his unparalleled expertise in Osteopathic Neuromusculoskeletal Medicine.
  • With a career spanning 35 years, Dr. Van Buskirk has made substantial contributions to the advancement of this specialized medical field.
  • Dr. Van Van Buskirk's exceptional expertise lies in Osteopathic Neuromusculoskeletal Medicine, where he has consistently demonstrated his commitment to diagnosing and treating musculoskeletal issues.

Thomas M. Krummel, MD Joins Silicon Valley Innovations, Inc. Board of Directors

Retrieved on: 
Wednesday, March 13, 2024
Vagina, Bacterial vaginosis, SVI, Amazon, Plague, Patient, Pharmacy, American Academy, Stanford University, Silicon, American College, Fungal infection, Woman, OTC, Asthma, Nose, HRG, AAAAI, Medicine

SILICON VALLEY, Calif., March 13, 2024 /PRNewswire/ -- Silicon Valley Innovations (SVI) announced today that Thomas M. Krummel, MD, an internationally acclaimed surgeon, former Chair of the Department of Surgery at Stanford University, and med-tech innovator, has joined the company's Board of Directors.

Key Points: 
  • SILICON VALLEY, Calif., March 13, 2024 /PRNewswire/ -- Silicon Valley Innovations (SVI) announced today that Thomas M. Krummel, MD, an internationally acclaimed surgeon, former Chair of the Department of Surgery at Stanford University, and med-tech innovator, has joined the company's Board of Directors.
  • "We're very fortunate to have Dr. Krummel joining us at SVI," says CEO and Founder of SVI, Gail Lebovic, MD.
  • "We share a vision for the future of medicine that includes creating clinically relevant medical technology and placing it into the hands of patients."
  • Dr. Krummel sees major potential clinical benefits and market opportunities for SVI's offerings.

AAOS Announces Research Funding for Orthopaedic Specialty Societies

Retrieved on: 
Tuesday, March 12, 2024
Research, Organization, Patient, AAOS, American Academy, MD, MBA, BOS, Pharmaceutical industry

ROSEMONT, Ill. , March 12, 2024 /PRNewswire/ -- The American Academy of Orthopaedic Surgeons' (AAOS) announced the recipients of the AAOS Board of Specialty Societies (BOS) Research Support Fund Awards. Two investigators and their sponsoring organizations will receive awards of $27,500 to $72,500 for a total of $100,000 in funding towards evidence-based research in musculoskeletal healthcare. All applications were reviewed for scientific merit through AAOS' Scientific Review Group, a workgroup consisting of AAOS members representing the AAOS Research and Quality Council, the BOS and the Orthopaedic Research and Education Foundation.

Key Points: 
  • ROSEMONT, Ill. , March 12, 2024 /PRNewswire/ -- The American Academy of Orthopaedic Surgeons' (AAOS) announced the recipients of the AAOS Board of Specialty Societies (BOS) Research Support Fund Awards.
  • Two investigators and their sponsoring organizations will receive awards of $27,500 to $72,500 for a total of $100,000 in funding towards evidence-based research in musculoskeletal healthcare.
  • All applications were reviewed for scientific merit through AAOS' Scientific Review Group, a workgroup consisting of AAOS members representing the AAOS Research and Quality Council, the BOS and the Orthopaedic Research and Education Foundation.
  • "Together with our partners at the orthopaedic specialty societies, the AAOS is supporting the advancement of scientific knowledge across the field of orthopaedics," said AAOS Research and Quality Council Chair David S. Jevsevar, MD, MBA, FAAOS.